Retrospective Cohort Study
Copyright ©The Author(s) 2020.
World J Gastrointest Endosc. Dec 16, 2020; 12(12): 542-554
Published online Dec 16, 2020. doi: 10.4253/wjge.v12.i12.542
Table 3 Concomitant therapy of the thirty patients on anti-mycobacterial antibiotic therapy that returned for follow-up
CR (n = 20)
PR + NR (n = 10)
P value
Concomitant biologic medication
Y, n (%)3 (15)3 (30)0.37
N, n (%)17 (85)7 (70)
Concomitant steroid medication
Y, n (%)13 (65)3 (30)0.12
N, n (%)7 (35)7 (70)
Concomitant IMD medication
Y, n (%)12 (60)1 (10)0.02
N, n (%)8 (40)9 (90)
Concomitant 5-ASA medication
Y, n (%)13 (65)4 (40)0.26
N, n (%)7 (35)6 (60)
CR: Complete resolution; PR: Partial resolution; NR: No resolution; Y: Yes; N: No; IMD: Immunomodulator; 5-ASA: 5-Aminosalicylate.